Active ingredient
Gemcitabine
41 finished FDA listings contain Gemcitabine as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- GEMCITABINE, GEMCITABINE HYDROCHLORIDE
- Dosage forms
- Injection, Powder, Lyophilized, For Solution, Injection, Solution, System
- Routes
- Intravenous, Intravesical
- Manufacturers / labelers
- 13
- Strengths listed
- 1 g/1 · 1 g/25ml · 1 g/26.3ml · 100 mg/ml · 2 g/50ml · 2 g/52.6ml · 200 mg/1 · 200 mg/5.26ml · 200 mg/5ml · 225 mg/1 · 38 mg/ml
- Brand names in FDA listings
- Avgemsi, Gemcitabine, Inlexzo
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 12574
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| ANDA 079183 | HOSPIRA INC | 2010-11-15 | 1 |
| ANDA 090799 | FRESENIUS KABI USA | 2011-05-16 | 5 |
| ANDA 091365 | DR REDDYS LABS LTD | 2011-07-25 | 6 |
| ANDA 078759 | TEYRO LABS | 2011-07-25 | 2 |
| ANDA 078339 | HOSPIRA | 2011-07-25 | 2 |
| NDA 200795 | HOSPIRA INC | 2011-08-04 | 6 |
| ANDA 202485 | JIANGSU HANSOH PHARM | 2013-05-07 | 2 |
| ANDA 204520 | GLAND | 2016-01-05 | 2 |
| NDA 209604 | ACCORD HLTHCARE | 2017-08-03 | 3 |
| ANDA 205242 | MYLAN LABS LTD | 2017-12-06 | 3 |
| ANDA 209077 | SAGENT PHARMS INC | 2018-07-20 | 1 |
| ANDA 212129 | MEITHEAL | 2020-12-11 | 2 |
| ANDA 213175 | HIKMA | 2023-03-07 | 3 |
| NDA 219920 | AVYXA HOLDINGS | 2025-06-27 | 2 |
| NDA 219683 | JANSSEN BIOTECH | 2025-09-09 | 1 |
Official labeling on DailyMed
- AVGEMSI (GEMCITABINE) INJECTION, SOLUTION [AVYXA PHARMA, LLC] · version 4 · 2026-07-28
- GEMCITABINE INJECTION, SOLUTION [HOSPIRA, INC.] · version 11 · 2026-06-03
- GEMCITABINE INJECTION, SOLUTION [HOSPIRA, INC.] · version 28 · 2026-04-29
- GEMCITABINE INJECTION, SOLUTION [HIKMA PHARMACEUTICALS USA INC.] · version 4 · 2025-11-17
- INLEXZO (GEMCITABINE INTRAVESICAL) SYSTEM [JANSSEN BIOTECH, INC] · version 1 · 2025-09-15
- GEMCITABINE (GEMCITABINE HYDROCHLORIDE) INJECTION, SOLUTION [MEITHEAL PHARMACEUTICALS INC.] · version 1 · 2025-07-25
- GEMCITABINE INJECTION, SOLUTION [SAGENT PHARMACEUTICALS] · version 8 · 2025-04-28
- GEMCITABINE (GEMCITABINE HYDROCHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [NORTHSTAR RX LLC] · version 4 · 2025-02-05
- GEMCITABINE (GEMCITABINE HYDROCHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MEITHEAL PHARMACEUTICALS INC.] · version 5 · 2025-02-05
- GEMCITABINE HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [TEYRO LABS PRIVATE LIMITED] · version 1 · 2025-01-10
- GEMCITABINE (GEMCITABINE HYDROCHLORIDE) INJECTION, SOLUTION [MYLAN INSTITUTIONAL LLC] · version 6 · 2024-11-27
- GEMCITABINE (GEMCITABINE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC · version 19 · 2024-10-22
Showing the 12 most recent of 19 labels.
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.